Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Bolger

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Pharmaceutical Sciences|October 22, 2021
Predicting Pharmacokinetics of Multisource Acyclovir Oral Products Through Physiologically Based Biopharmaceutics ModelingMauricio A García, Michael B Bolger, Sandra Suarez-Sharp, et al.
Pharmaceutical Research|July 13, 2006
In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effectMarija Tubic, Daniel Wagner, Hilde Spahn-Langguth, et al.
Journal of Pharmaceutical Sciences|October 15, 2018
The Irrelevance of In Vitro Dissolution in Setting Product Specifications for Drugs Like Dextromethorphan That are Subject to Lysosomal TrappingMichael B Bolger, Joyce S Macwan, Muhammad Sarfraz, et al.
The AAPS Journal|June 25, 2021
PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Kidney in Pregnant Subjects and FetusKe Xu Szeto, Maxime Le Merdy, Benjamin Dupont, et al.
Pharmaceutics|January 23, 2024
PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Metabolism in Pregnant Subjects and FetusesMaxime Le Merdy, Ke Xu Szeto, Jeremy Perrier, et al.
Pharmaceutical Research|August 18, 2009
Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporterLiya Xu, Ian S Haworth, Ashutosh A Kulkarni, et al.
Molecular Pharmaceutics|January 17, 2018
Physiologically Based Pharmacokinetic Modeling in Lead Optimization. 1. Evaluation and Adaptation of GastroPlus To Predict Bioavailability of Medchem SeriesPankaj R Daga, Michael B Bolger, Ian S Haworth, et al.
Pharmaceutical Research|October 22, 2010
Predicting the effect of fed-state intestinal contents on drug dissolutionEce Dilber Gamsiz, Mukul Ashtikar, John Crison, et al.
Molecular Pharmaceutics|January 17, 2018
Physiologically Based Pharmacokinetic Modeling in Lead Optimization. 2. Rational Bioavailability Design by Global Sensitivity Analysis To Identify Properties Affecting BioavailabilityPankaj R Daga, Michael B Bolger, Ian S Haworth, et al.
Pharmaceutical Research|May 15, 2020
Translational Modeling Strategies for Orally Administered Drug Products: Academic, Industrial and Regulatory PerspectivesSandra Suarez-Sharp, Anders Lindahl, Tycho Heimbach, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical Sciences|October 22, 2021
Predicting Pharmacokinetics of Multisource Acyclovir Oral Products Through Physiologically Based Biopharmaceutics ModelingMauricio A García, Michael B Bolger, Sandra Suarez-Sharp, et al.
Pharmaceutical Research|July 13, 2006
In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effectMarija Tubic, Daniel Wagner, Hilde Spahn-Langguth, et al.
Journal of Pharmaceutical Sciences|October 15, 2018
The Irrelevance of In Vitro Dissolution in Setting Product Specifications for Drugs Like Dextromethorphan That are Subject to Lysosomal TrappingMichael B Bolger, Joyce S Macwan, Muhammad Sarfraz, et al.
The AAPS Journal|June 25, 2021
PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Kidney in Pregnant Subjects and FetusKe Xu Szeto, Maxime Le Merdy, Benjamin Dupont, et al.
Pharmaceutics|January 23, 2024
PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Metabolism in Pregnant Subjects and FetusesMaxime Le Merdy, Ke Xu Szeto, Jeremy Perrier, et al.
Pharmaceutical Research|August 18, 2009
Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporterLiya Xu, Ian S Haworth, Ashutosh A Kulkarni, et al.
Molecular Pharmaceutics|January 17, 2018
Physiologically Based Pharmacokinetic Modeling in Lead Optimization. 1. Evaluation and Adaptation of GastroPlus To Predict Bioavailability of Medchem SeriesPankaj R Daga, Michael B Bolger, Ian S Haworth, et al.
Pharmaceutical Research|October 22, 2010
Predicting the effect of fed-state intestinal contents on drug dissolutionEce Dilber Gamsiz, Mukul Ashtikar, John Crison, et al.
Molecular Pharmaceutics|January 17, 2018
Physiologically Based Pharmacokinetic Modeling in Lead Optimization. 2. Rational Bioavailability Design by Global Sensitivity Analysis To Identify Properties Affecting BioavailabilityPankaj R Daga, Michael B Bolger, Ian S Haworth, et al.
Pharmaceutical Research|May 15, 2020
Translational Modeling Strategies for Orally Administered Drug Products: Academic, Industrial and Regulatory PerspectivesSandra Suarez-Sharp, Anders Lindahl, Tycho Heimbach, et al.
Pageof 4